Jianmin Pharmaceutical Group Co Ltd. Class ASSE: 600976

"Jianmin Pharmaceutical Group Co., Ltd."Semi-annual Report for 2026

Aug 20, 2026 · Issued by Jianmin Pharmaceutical Group Co Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Jianmin Pharmaceutical Group Co Ltd. Class A

"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Convening the 2026 Semi-annual Performance BriefingAug 18
"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Inclusion of the Company's Products in the "National Essential Medicines List"Jul 10
"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei JurisdictionJul 2
"Jianmin Pharmaceutical Group Co., Ltd."Announcement on Obtaining Notice of Approval for Drug Clinical TrialsJul 1

All Jianmin Pharmaceutical Group Co Ltd. Class A news releases